11.02.2016 • News

Air Liquide Buys Brazil’s Vic Pharma

French industrial gases producer Air Liquide has strengthened its presence in the South American healthcare market through the acquisition of a majority stake in Brazil’s Vic Pharma.

Air Liquide’s hygiene and hospital disinfection subsidiary Schülke has taken a 75% stake in the company for an undisclosed sum.

Vic Pharma is the second biggest independent player in Brazil’s hygiene market, offering a broad range of products for disinfecting surfaces, instruments and medical devices, as well as antiseptic solutions for pre- or post-operative care.

The company is located in Taquaritinga, Sao Paulo, and has more than 100 employees. It generated revenue of around €8 million in 2015.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Test



Close